Senior insider sale
CEO at EAGLE PHARMACEUTICALS, INC. — senior position signals high conviction
$1.25M
60K shares
What this filing means
TARRIFF SCOTT plans to sell 60K shares of EAGLE PHARMACEUTICALS, INC. valued at approximately $1.25M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/11/2023ACC: 0001972649-23-000001
DirectorOfficer· CEO
Since Jun 2018
60K
Shares to sell
$1.25M
Approx. market value
60K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months5
Vesting of Restricted Stock and Options
Cash
1/23/2022
12.38KVesting of Restricted Stock and Options
Cash
1/5/2022
14.57KVesting of Restricted Stock and Options
Cash
1/23/2021
10.69KVesting of Restricted Stock and Options
CAsh
1/5/2021
14.57KVesting of Restricted Stock and Options
Cash
1/23/2020
7.78KTotal acquired60K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/23/2022 | Vesting of Restricted Stock and Options Cash | 12.38K | — |
1/5/2022 | Vesting of Restricted Stock and Options Cash | 14.57K | — |
1/23/2021 | Vesting of Restricted Stock and Options Cash | 10.69K | — |
1/5/2021 | Vesting of Restricted Stock and Options CAsh | 14.57K | — |
1/23/2020 | Vesting of Restricted Stock and Options Cash | 7.78K | — |
| Total | 60K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
60K
Market value
$1.25M
5/11/2023
Total
Units
60K
Value
$1.25M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/11/2023 | 60K | $1.25M | NASDAQ | Planned |
| Total | 60K | $1.25M | ||